title: The effects of L-sulpiride on reflux oesophagitis.
abstract: Prokinetic drugs are commonly used for treatment of reflux oesophagitis. Although much data has been collected in clinical trials, their therapeutic effects are still uncertain. In this study the effects of L-sulpiride, if any, were examined when used to treat reflux oesophagitis in thirty patients. The patients were divided into two groups: a control group and a group given 25 mg t.i.v./day, p.o. of L-sulpiride for 30 days. They were treated as outpatients and had endoscopic, histological and ultrastructural examinations on the 30th and 60th days of treatment. It was found that the symptoms of patients with reflux oesophagitis were alleviated and the endoscopic and ultrastructural lesions of patients with minor oesophagitis were also decreased. In other patients, symptoms improved without resolution of the lesions. The authors conclude, therefore, that L-sulpiride would be appropriate treatment for Grade I cases.
authors.affiliation: Department of Physiopathological Surgery, University of Milan, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Trabucchi
authors.forename: E
authors.initials: E
authors.lastname: Radaelli
authors.forename: L
authors.initials: L
authors.lastname: Castoldi
authors.forename: P
authors.initials: P
authors.lastname: Abelli
authors.forename: A
authors.initials: A
authors.lastname: Brambilla
authors.forename: G
authors.initials: G
authors.lastname: Fichera
authors.forename: S
authors.initials: S
authors.lastname: Diamantini
authors.forename: M
authors.initials: M
authors.lastname: Pace
authors.forename: D
authors.initials: D
authors.lastname: Foschi
mesh_terms: D004311:Double-Blind Method; D016145:Endoscopy, Digestive System; D004942:Esophagitis, Peptic / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013469:Sulpiride / Q000494:pharmacology*
chemical_list: D013469:Sulpiride